Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.

Bao B, Ali S, Kong D, Sarkar SH, Wang Z, Banerjee S, Aboukameel A, Padhye S, Philip PA, Sarkar FH

Open source

DOI
10.1371/journal.pone.0017850
Published
2011 Mar 9
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0017850,
  title = {Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.},
  author = {Bao B and Ali S and Kong D and Sarkar SH and Wang Z and Banerjee S and Aboukameel A and Padhye S and Philip PA and Sarkar FH},
  year = {2011},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0017850},
  url = {https://doi.org/10.1371/journal.pone.0017850}
}

RIS

TY  - JOUR
TI  - Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.
AU  - Bao B
AU  - Ali S
AU  - Kong D
AU  - Sarkar SH
AU  - Wang Z
AU  - Banerjee S
AU  - Aboukameel A
AU  - Padhye S
AU  - Philip PA
AU  - Sarkar FH
PY  - 2011
JO  - PloS one
DO  - 10.1371/journal.pone.0017850
UR  - https://doi.org/10.1371/journal.pone.0017850
ER  - 

APA

B, B., S, A., D, K., SH, S., Z, W., S, B., A, A., S, P., PA, P., & FH, S. (2011). Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.. PloS one. https://doi.org/10.1371/journal.pone.0017850

Source records